News & Updates

Biofeedback-virtual reality device beneficial in chronic migraine
Biofeedback-virtual reality device beneficial in chronic migraine
18 Apr 2023

For individuals with chronic migraine, frequent use of a portable biofeedback-virtual reality device leads to a decreased frequency of acute analgesic drug use and an improvement in depression, as shown in a pilot study.

Biofeedback-virtual reality device beneficial in chronic migraine
18 Apr 2023
MV-140 vaccine proven safe, effective in recurrent UTI
MV-140 vaccine proven safe, effective in recurrent UTI
18 Apr 2023 byStephen Padilla

Immunotherapy with MV-140 (Uromune) successfully prevents urinary tract infections (UTIs) in patients suffering from recurrent UTIs, suggest the results of a prospective study presented at the 38th Annual EAU Congress (EAU 2023).

MV-140 vaccine proven safe, effective in recurrent UTI
18 Apr 2023
Excess CVD risk found in women with endometriosis
Excess CVD risk found in women with endometriosis
17 Apr 2023

Endometriosis appears to be associated with a significantly elevated risk of cardiovascular disease (CVD), specifically ischaemic heart disease and cerebrovascular disease, as suggested in a study.

Excess CVD risk found in women with endometriosis
17 Apr 2023
NSAID use ups risk of heart failure in T2DM patients
NSAID use ups risk of heart failure in T2DM patients
17 Apr 2023

Use of nonsteroidal anti-inflammatory drugs (NSAIDs) tends to elevate the risk of first-time hospitalization for heart failure (HF) in patients with type 2 diabetes mellitus (T2DM), a study has shown. In addition, those with advanced age, elevated haemoglobin (Hb) A1c levels, and new users are particularly at higher risk.

NSAID use ups risk of heart failure in T2DM patients
17 Apr 2023